ArticleImplementation science communications2026
A qualitative assessment of readiness to sustain Rapid Start ART in 14 publicly funded HIV clinics in the United States.
Article in Implementation science communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Resuscitation of a patient with progressive AIDS-related opportunistic infections complicated by MODS through multidisciplinary collaboration: case report.AIDS research and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundCurrent standards advise starting HIV antiretroviral therapy (ART) as soon as possible with the goal of achieving viral suppression. Applying the domains of a sustainability framework as a roadmap, we examine factors and strategies impacting readiness to sustain Rapid Start ART (RS-ART) across 14 sites participating in a national initiative that successfully implemented this intervention to link people with HIV to initiate ART treatment within seven days after linkage or re-engagement in care. While sustainability entails the ongoing delivery of a previously implemented intervention, factors and strategies for sustaining RS-ART have not been well-defined or studied.
methodsWe conducted one-on-one semi-structured interviews with a purposeful sample of key informants from each of the 14 sites. Data were organized using Dedoose and analyzed using thematic analysis.
resultsWe conducted a total of 27 interviews with decision-makers and key staff implementing RS-ART. We identified a continuum across the sites, reflecting three different stages of readiness to sustain RS-ART. "Well-oiled machine" sites had comprehensive sustainability plans in place with RS-ART established as their current standard practice, supported by secured funding and organizational capacity. "On track" sites demonstrated a clear vision toward sustaining RS-ART, with progress contingent on securing funding and finalizing staffing plans. "To be determined" sites faced challenges, expressing uncertainty about obtaining necessary funding and determining sufficient human resources to sustain RS-ART. While feasibility and acceptability of RS-ART, driven by improved service and patient outcomes, were high across all sites, available funding and the necessary human resources were the two critical, interrelated factors impacting readiness to sustain RS-ART.
conclusionsSites positioned to sustain RS-ART were able to secure funding for the necessary staff positions to effectively integrate it as standard of care. Future funding of HIV care programs must provide sufficient resources for all individuals to be offered RS-ART services to improve life expectancy, manage HIV as a chronic disease and prevent transmission to others. Given the dynamic nature of sustainability, future longitudinal studies are needed to evaluate RS-ART sustainability outcomes and its long-term effectiveness after it has been sustained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.